Approval · Notice of Compliance 2611 · 2001
ISOPTIN: Notice of Compliance 2611
Issued June 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2611
- Date
- June 22, 2001
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antianginal/antiarrhythmic/antihypertensive agent
Products in this notice
Medicinal ingredients
- VERAPAMIL HCL 80 MG per TAB
- VERAPAMIL HCL 120 MG per TAB